RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm

Blood Adv. 2025 May 22:bloodadvances.2025016374. doi: 10.1182/bloodadvances.2025016374. Online ahead of print.
No abstract available